VALIC Company I Health Sciences (VCHSX)
* As of 28-Feb-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Reports available for VCHSX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.15%|
Performance & Risk
|5y Avg Return:||32.94%|
|Rank in Category (ytd):||39|
|% Rank in Category (ytd):||29.77%|
|Morningstar Risk Rating:||4|
The investment seeks long-term capital growth.
The fund normally invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). It can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S. View More